Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more
Beihai Gofar Marine Biological Industry Co Ltd (600538) - Total Assets
Latest total assets as of September 2025: CN¥964.41 Million CNY
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) holds total assets worth CN¥964.41 Million CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Beihai Gofar Marine Biological Industry Co Ltd - Total Assets Trend (1999–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Beihai Gofar Marine Biological Industry Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Beihai Gofar Marine Biological Industry Co Ltd's total assets of CN¥964.41 Million consist of 50.8% current assets and 49.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.0% |
| Accounts Receivable | CN¥256.23 Million | 26.5% |
| Inventory | CN¥82.94 Million | 8.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥27.29 Million | 2.8% |
| Goodwill | CN¥138.46 Million | 14.3% |
Asset Composition Trend (1999–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beihai Gofar Marine Biological Industry Co Ltd's current assets represent 50.8% of total assets in 2024, an increase from 41.7% in 1999.
- Cash Position: Cash and equivalents constituted 15.0% of total assets in 2024, up from 7.6% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 7.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 26.5% of total assets.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Total Assets
Key competitors of Beihai Gofar Marine Biological Industry Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
ADAMA Ltd
SHE:000553
|
China | CN¥49.93 Billion |
|
Grand Industrial Holding Co Ltd
SHE:000626
|
China | CN¥8.43 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
China | CN¥19.38 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
China | CN¥9.46 Billion |
Beihai Gofar Marine Biological Industry Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Beihai Gofar Marine Biological Industry Co Ltd generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Beihai Gofar Marine Biological Industry Co Ltd is currently not profitable relative to its asset base.
Beihai Gofar Marine Biological Industry Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.02 | 3.61 | 2.38 |
| Quick Ratio | 3.28 | 3.01 | 2.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥378.44 Million | CN¥ 361.35 Million | CN¥ 294.16 Million |
Beihai Gofar Marine Biological Industry Co Ltd - Advanced Valuation Insights
This section examines the relationship between Beihai Gofar Marine Biological Industry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.37 |
| Latest Market Cap to Assets Ratio | 0.38 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | CN¥966.75 Million |
| Market Capitalization | $371.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beihai Gofar Marine Biological Industry Co Ltd's assets below their book value (0.38 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Beihai Gofar Marine Biological Industry Co Ltd's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Beihai Gofar Marine Biological Industry Co Ltd (1999–2024)
The table below shows the annual total assets of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥966.75 Million | -8.41% |
| 2023-12-31 | CN¥1.06 Billion | -7.58% |
| 2022-12-31 | CN¥1.14 Billion | +5.48% |
| 2021-12-31 | CN¥1.08 Billion | +1.60% |
| 2020-12-31 | CN¥1.07 Billion | +42.09% |
| 2019-12-31 | CN¥750.05 Million | -1.75% |
| 2018-12-31 | CN¥763.38 Million | -1.72% |
| 2017-12-31 | CN¥776.75 Million | -18.90% |
| 2016-12-31 | CN¥957.71 Million | -2.67% |
| 2015-12-31 | CN¥984.02 Million | -0.72% |
| 2014-12-31 | CN¥991.16 Million | +43.49% |
| 2013-12-31 | CN¥690.74 Million | +12.50% |
| 2012-12-31 | CN¥613.98 Million | -11.85% |
| 2011-12-31 | CN¥696.54 Million | -1.45% |
| 2010-12-31 | CN¥706.76 Million | -25.09% |
| 2009-12-31 | CN¥943.42 Million | -21.85% |
| 2008-12-31 | CN¥1.21 Billion | -7.72% |
| 2007-12-31 | CN¥1.31 Billion | +0.54% |
| 2006-12-31 | CN¥1.30 Billion | +2.64% |
| 2005-12-31 | CN¥1.27 Billion | +21.28% |
| 2004-12-31 | CN¥1.05 Billion | +41.20% |
| 2003-12-31 | CN¥740.21 Million | +214.69% |
| 2002-12-31 | CN¥235.22 Million | +13.82% |
| 2001-12-31 | CN¥206.66 Million | +5.45% |
| 2000-12-31 | CN¥195.98 Million | +17.39% |
| 1999-12-31 | CN¥166.95 Million | -- |